India’s national research organization known as the Indian Council of Medical Research (ICMR) is now reviewing the benefits of ivermectin and doxycycline as a potential therapy for COVID-19. The combination was tested by Dr. Tarek Alam at the Bangladesh Medical College who interviewed with TrialSite News. Hailed as “astounding results” in the hospital approved off-label protocol study of 60 patients, they have all recovered. This got the attention of the national research agency in India.
The interest in ivermectin accelerates worldwide now as the world’s second most populous country’s elite national research agency, ICMR, investigates the U.S. Food and Drug Administration (FDA)-approved anti-parasite drug. Nivedita Gupta, senior scientist with ICMR, reports, “We are closely studying the drug ivermectin and its possible efficacy against COVID-19. It needs to be studied more closely," reports The Print in India.
The Bangladesh Medical College
As TrialSite News reported in its interview with Dr. Tarek Alam, the Bangladesh Medical College approved an off-label protocol to treat sick COVID-19 patients with the ivermectin and Doxycycline combination yielding “astounding result...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).